Elsevier

Fitoterapia

Volume 87, June 2013, Pages 57-64
Fitoterapia

Curcumin attenuates allergic airway inflammation by regulation of CD4+CD25+ regulatory T cells (Tregs)/Th17 balance in ovalbumin-sensitized mice

https://doi.org/10.1016/j.fitote.2013.02.014Get rights and content

Abstract

The present study aimed to determine the protective effects and the underlying mechanisms of curcumin on ovalbumin (OVA)-induced allergic inflammation in a mouse model of allergic asthma. Asthma mice model was established by ovalbumin. A total of 60 mice were randomly assigned to six experimental groups: control, model, dexamethasone (2 mg/kg), and curcumin (50 mg/kg, 100 mg/kg, 200 mg/kg). Airway resistance (Raw) was measured by the forced oscillation technique, differential cell count in BAL fluid (BALF) was measured by Wright–Giemsa staining, histological assessment was measured by hematoxylin and eosin (HE) staining, BALF levels of Treg/Th17 cytokines were measured by enzyme-linked immunosorbent assay, Treg cells and Th17 cells were evaluated by flow cytometry (FCM). Our study demonstrated that curcumin inhibited OVA-induced increases in eosinophil count; interleukin (IL)-17A level were recovered in bronchoalveolar lavage fluid increased IL-10 level in bronchoalveolar lavage fluid. Histological studies demonstrated that curcumin substantially inhibited OVA-induced eosinophilia in lung tissue. Flow cytometry (FCM) studies demonstrated that curcumin remarkably inhibited Th17 cells and significantly increased Treg cells. The results in vivo show ovalbumin-induced significantly broke Treg/Th17 balance; curcumin treatments markedly attenuated the inflammatory in asthma model by regulating Treg/Th17 balance. Our findings support the possible use of curcumin as a therapeutic drug for patients with allergic asthma.

Graphical abstract

Curcumin attenuates allergic airway inflammation by regulation of CD4+CD25+ regulatory T cells (Tregs)/Th17 balance.

  1. Download : Download high-res image (70KB)
  2. Download : Download full-size image

Introduction

Asthma is a clinical diagnosis based on episodic symptoms and variable airway obstruction [1]. It has been generally recognized that the disease is also characterized by variable degrees of chronic inflammation and structural alterations in the airways [2]. Allergen-specific CD4+T cells are believed to play a pivotal role in the development of asthma [3]. Traditionally, it is thought that TH2-mediated chronic inflammation triggers and perpetuates a vicious circle of tissue injury–tissue repair culminating in remodeling. Th2 cells synthesize high levels of interleukin IL-4, IL-5, and IL-13, which lead to the production of allergen-specific immunoglobulin (Ig)E and the release of mediators from mast cells [4]. Th1 cells suppress Th2 immune responses by secreting interferon IFN-γ. IL-4 induces class switching in IgG1 and IgE, where as IFN-γ is involved in IgG2a class switching. Accordingly, estimation of IgE production and Th1/Th2 cytokine balance is an important tool in the evaluation of asthma [5]. Recently, regulatory T cells (Treg cells) and T-helper17 (Th17) cells have been described as two distinct subsets from Th1 and Th2 cells that play opposite roles in vivo [6]. Treg cells expressing the forkhead/winged helix transcription factor (Foxp3) have an anti-inflammatory role and maintain tolerance to self-components through direct contact with cells or by releasing anti-inflammatory cytokines such as IL-10 [7]. Th17 cells expressing retinoic acid receptor-related orphan receptor γt (RORγt) play crucial roles in the induction of autoimmune tissue injuries and inflammation by producing cytokines such as IL-17, tumor necrosis factor (TNF)-α, and IL-6. The balance between Th17 and Treg cell action may be important in the development/prevention of inflammatory and autoimmune diseases such as asthma [8].

Curcumin is an illustrious dietary ingredient of the Indian subcontinent [9]. Curcumin, in the form of the herbal powder, turmeric (given the name curry spice by the British), has been used for centuries as an anti-inflammatory remedy in Asian [10]. Turmeric has been studied extensively for its biological activities, predominantly as follows: antiinflammatory and antiarthritic [11], antioxidant [12], antimicrobial [13], anti-leishmanial [14], hepatoprotective [15], anticancer [16], vasodilator [17], hypolipidaemic [18], antiplatelet [19], hypoglycaemic [20], choleretic [21], antiulcer [22], antiscabies [23], wound healing [24], immunomodulatory [25], neuroprotective [26], antidepressant [27] and effective in Alzheimer's disease [28]. Curcumin has been used for the treatment of various inflammatory diseases in certain countries [29]. Curcumin has been reported to exert an anti-inflammatory effect, through desensitizing the nociceptor ion channel TRPA1 (As TRPA1 is specific to certain nociceptors, it is an attractive target for various therapeutic conditions such as pain, asthma, and cough) [30] and curcumin has been reported to exert an anti-asthma effect, through NF-κB inhibition [31]. The purposes of this study were to determine whether curcumin exerts an anti-inflammatory effect via regulation of CD4+CD25+ regulatory T cells (Tregs)/Th17 balance in ovalbumin-sensitized mice.

Section snippets

Chemicals and reagents

Curcumin (purity > 95%) was purchased from National Institutes for Food and Drug Control (Beijing, China). Dexamethasone was purchased from Xiansheng drug store (Nanjing, China). Ovalbumin (OVA), methacholine (Sigma Chemical Co., St Louis, MO), aluminum hydroxide (Pierce Biotechnology, Rockford, USA), and Wright–Giemsa staining (Nanjing Jiancheng Bioengineering institute, Nanjing, China). ELISA kits (R&D, Minneapolis, MN, USA).

Animals

Animal experiment was carried out in accordance with the Guidelines

Effect of curcumin on airway resistance (Raw)

Measurements of airway resistance (Raw), during methacholine-induced constriction are shown in (Fig. 2). The Raw value of the OVA-challenged group was significantly higher than that of the PBS control group (P < 0.05) when concentrations of 0.125–1.000 mg ml 1 methacholine. OVA-sensitized and-challenged mice treated with curcumin, displayed a reduced mean Raw upon exposure to 0.5–1.0 mg ml 1 compared with the response of the OVA-sensitized and -challenged group. Positive control mice given with

Discussion

Asthma, a chronic inflammatory disease of the airways, affects many individuals worldwide. The disease may cause severe morbidity, and even mortality if exacerbated. To date, a variety of drugs have been developed to treat asthma; these include steroids, leukotriene inhibitors, mast cell stabilizers, and β2 adrenergic agonists. Many nature products were commonly used to treat asthma, but the therapeutic efficacies and modes of action of such medicines are currently unclear. Here, using an

Acknowledgments

This work was supported by a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.

References (45)

  • S. Toosi et al.

    Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid

    Med Hypotheses

    (2010)
  • Global Initiative for Asthma

    Global strategy for asthma management and prevention

  • J.M. Brewer et al.

    Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4-or IL-13-mediated signaling

    J Immunol

    (1999)
  • C.T. Weaver et al.

    Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective

    Nat Rev Immunol

    (2009)
  • S. Sakaguchi et al.

    Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

    Immunol Rev

    (2006)
  • E. Bettelli et al.

    T(H)-17 cells in the circle of immunity and autoimmunity

    Nat Immunol

    (2007)
  • B.B. Aggarwal et al.

    Curcumin: the Indian solid gold

    Adv Exp Med Biol

    (2007)
  • D. Chandra et al.

    Anti-inflammatory and anti-arthritic activity of volatile oil of Curcuma longa (Haldi)

    Indian J Med Res

    (1972)
  • S. Toda et al.

    Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa L

    Chem Pharm Bull

    (1985)
  • J. Lutomski et al.

    Effect of an alcohol extract and of active ingredients from Curcuma longa on bacteria and fungi (author's transl)

    Planta Med

    (1974)
  • D.C. Gomes et al.

    Total synthesis and anti-leishmanial activity of some curcumin analogues

    Arzneimittelforschung Drug Res

    (2002)
  • Y. Kiso et al.

    Antihepatotoxic principles of Curcuma longa rhizomes

    Planta Med

    (1983)
  • Cited by (83)

    View all citing articles on Scopus
    1

    Chunhua Ma and Zhanqiang Ma contributed equally to this work.

    View full text